Growth factors and pathogenesis
Md Soriful Islam1, Stefania Greco2, Milijana Janjusevic2
1Department of Experimental and Clinical Medicine, Faculty of Medicine, Polytechnic University of Marche, Ancona, Italy; Biotechnology and Microbiology Laboratory, Department of Botany, University of Rajshahi, Rajshahi, 6205, Bangladesh.
Best Practice & Research. Clinical Obstetrics & Gynaecology
|November 4, 2015
Summary
Growth factors are key to uterine leiomyoma development. Understanding their signaling pathways is crucial for targeting fibroid growth and related processes like inflammation and fibrosis.
Area of Science:
- Reproductive biology
- Cell signaling
- Molecular medicine
Background:
- Growth factors are polypeptide ligands crucial for cell functions like proliferation and tissue repair.
- Aberrant growth factor signaling is implicated in various diseases, including uterine leiomyomas.
Purpose of the Study:
- To review the role of growth factors and their signaling pathways in uterine leiomyoma pathogenesis.
- To highlight the molecular mechanisms underlying fibroid development and growth.
Main Methods:
- Literature review of studies on growth factors and uterine leiomyomas.
- Analysis of identified differentially expressed growth factors and their signaling cascades.
Main Results:
- Multiple growth factors are differentially expressed in leiomyoma and myometrial cells.
- Activated signaling pathways include Smad 2/3, ERK 1/2, PI3K, and β-catenin.
- These pathways regulate key fibroid processes: inflammation, proliferation, angiogenesis, and fibrosis.
Conclusions:
- Growth factors and their signaling pathways are central to uterine leiomyoma pathogenesis.
- Targeting these pathways offers potential therapeutic strategies for fibroids.
Related Concept Videos
01:28Role of Hematopoietic Growth Factors
4.3K
Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Thrombopoietin (TPO), mainly released by the liver,...
4.3K
01:16TGF - β Signaling Pathway
10.9K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.9K
02:38Mitogens and the Cell Cycle
8.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.4K
02:38Mitogens and the Cell Cycle
5.9K
5.9K
01:24Regulation of Angiogenesis and Blood Supply
4.0K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
4.0K
03:14Notch Signaling Pathway
6.9K
The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
6.9K